Rekombinanter ITGAL (Efalizumab Biosimilar) Antikörper

Produktnummer ABIN5581189

Produktdetails anti-ITGAL (Efalizumab Biosimilar) Antikörper

Target: ITGAL (Efalizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Monoklonal

Konjugat: Dieser ITGAL (Efalizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Blocking Peptide (BP)

Verwendungszweck: Recombinant rabbit monoclonal antibody raised against human ITGAL.

Kreuzreaktivität: Human

Immunogen: Original antibody is raised against a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.

Klon: Hu1124

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Blocking
Flow Cytometry (1 μg/mL)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS, pH 7.2 (0.02 % Proclin 300).

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Details zu ITGAL (Efalizumab Biosimilar)

Target: ITGAL (Efalizumab Biosimilar)

Abstract: ITGAL (Efalizumab Biosimilar) Produkte

Synonyme: CD11A antikoerper, LFA-1 antikoerper, LFA1A antikoerper, integrin subunit alpha L antikoerper, ITGAL antikoerper

Substanzklasse: Biosimilar

Hintergrund: Full Gene Name: integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1, alpha polypeptide)
Synonyms: CD11A,LFA-1,LFA1A

Gen-ID: 3683

UniProt: P20701